Twin to Twin Transfusion
Conditions
Keywords
fetoscopic laser photocoagulation, TTTS, uterine entry, direct entry, Seldinger technique, chorioamniotic membrane separation, CAS
Brief summary
The purpose of this study is to evaluate whether the entry technique surgeons use to get inside the uterus to perform fetoscopic laser photocoagulation for twin-to-twin transfusion syndrome has an effect on the rates of chorioamniotic membrane separation.
Detailed description
Patients who choose to undergo fetoscopic selective laser photocoagulation (SFLP) at Texas Children's Fetal Center will be offered participation in this research study by study investigators. Description of study rationale and design and a focused interview by the study coordinator to afford potential participants a formal opportunity to examine what they have learned about the research study in the course of their evaluation and discuss how they feel about enrolling in the research study. Once the patient is deemed eligible the informed consent process will be reviewed. If patients elect to participate in the study, informed consent will be obtained, and participants will be provided a copy of the signed consent. After consent has been obtained, participants will be randomized into two groups ("direct entry" and "Seldinger technique"). Procedure: Selective laser photocoagulation (SFLP) is standard of care for the treatment of complicated monochorionic twin pregnancies. Entry into the uterus for SFLP is achieved under ultrasound guidance using one of two accepted methods, direct entry or the Seldinger technique. Intravenous sedation with local anesthesia at the site of insertion has been found to provide sufficient maternal anesthesia for the procedure. Group I - Direct entry: The surgeon will gain access to the uterus by inserting a sharp trocar through a small incision in the skin. After access has been established, the trocar is removed and a small tube called a cannula is left in place. Group II - Seldinger technique: The surgeon will gain access to the uterus by inserting needle through a small incision in the skin and run a guide wire through the needle so a thin tube called a cannula can be placed over the wire. Follow-Up: Participants will be monitored after the procedure and upon discharge from the hospital they are free to resume care with their primary doctor. Investigators will collect follow-up data on the health of the participant and the babies until the babies turn one month old.
Interventions
Patients who choose to undergo fetoscopic selective laser photocoagulation for complicated monochorionic-diamniotic twin pregnancies with twin-to-twin transfusion syndrome will be offered participation in the study. All participants will undergo selective laser photocoagulation and entry into the uterus will be achieved using one of two accepted methods, either direct entry or the Seldinger technique.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients who are eligible and elect to undergo fetoscopic selective laser photocoagulation for complicated monochorionic-diamniotic twin pregnancies with twin-to-twin transfusion syndrome. * Patients will be between 16 0/7 weeks and 26 0/7 weeks gestational age.
Exclusion criteria
* Patients who do not elect to undergo fetoscopic laser photocoagulation for the treatment of complicated monochorionic-diamniotic twin pregnancies with twin-to-twin transfusion syndrome. * Triplets and higher order multiple gestations. * Patients who are less than 16 0/7 weeks or greater than 26 0/7 weeks gestational age. * Patients with a short cervix (less than 1.5 cm). * Patients with a known subchorionic hemorrhage.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rate of Immediate Chorioamniotic Membrane Separation (CAS) | Up to hospital discharge post-procedure (up to 5 days) | Number of participants that have chorioamniotic membrane separation within 24 hours of the procedure. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Rate of Chorioamniotic Membrane Separation (CAS) | From the post-surgical period (outside the first 24 hours) until delivery, up to 25 weeks | Number of participants that have chorioamniotic membrane separation outside the first 24 hours hours following the procedure |
| Gestational Age at Delivery | At delivery | Gestational age at the time of delivery |
| Preterm Birth | At delivery | Number of participants that deliver at \<37 weeks gestation |
| Procedure to Delivery Interval | At delivery | Days between the participant's procedure and when the babies are delivered |
| Placental Abruption | Up to hospital discharge post-procedure (up to 5 days) | As measured by presence in medical record |
| Chorioamnionitis | Up to hospital discharge post-procedure (up to 5 days) | As measured by presence in medical record |
| Septostomy | Up to hospital discharge post-procedure (up to 5 days) | As measured by presence in medical record |
| Preterm Premature Rupture of Membranes (PPROM) | At delivery | As measured by presence in medical record |
Countries
United States
Contacts
Baylor College of Medicine